Nuclear Factor Kappa B: Important Transcription Factor and Therapeutic Target
The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Abstract
Nuclear factor kappa B (NF‐κB) is an ubiquitous rapid response transcription factor in cells involved in immune and inflammatory reactions, and exerts its effect by expressing cytokines, chemokines, cell adhesion molecules, growth factors, and immunoreceptors. In this manner, NF‐κB contributes to immunologically mediated diseases such as allograft rejection, rheumatoid arthritis, and bronchial asthma. The prototypic inducible form of NF‐κB is a heterodimer composed of NF‐kB1 and RelA, which both belong to the NF‐κB/Rel family of proteins. Inactive NF‐κB is present in the cytoplasm complexed with an inhibitory protein, IκB. NF‐κB is activated by a number of incoming signals from the cell surface. Released from IκB inhibition, NF‐κB translocates into the nucleus and binds to the κB motif of the target gene. The NF‐κB activation process can be inhibited by pharmacologic agents at each activation step. Glucocorticoids inhibit NF‐κB by directly associating with NF‐κB or by upregulating IκB expression. Cyclosporin and tacrolimus prevent NF‐κB activation by inhibiting the action of calcineurin, a phosphatase that indirectly induces IκB degradation. Deoxyspergualin inhibits NF‐κB by blocking its nuclear translocation. Aspirin and salicylates inhibit upstream events inducing IκB phosphorylation. Tepoxalin and antioxidants inhibit NF‐κB activation by influencing the redox state of the cell. Further research is required to develop more specific inhibitors to treat diseases mediated by NF‐κB.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
Baldwin, A. S. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.649 · Cited by 4,979
Function and Activation of NF-kappaB in the Immune System
Baeuerle, P. A., & Henkel, T. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001041 · Cited by 4,745
Schreck, R., Rieber, P., & Baeuerle, P. A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07761.x · Cited by 3,816
Baeuerle, P. A., & Baltimore, D. (1996) · Cell · doi:10.1016/s0092-8674(00)81318-5 · Cited by 3,001
Multiple nuclear factors interact with the immunoglobulin enhancer sequences
Sen, R., & Baltimore, D. (1986) · Cell · doi:10.1016/0092-8674(86)90346-6 · Cited by 2,752
Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A., & Karin, M. (1995) · Science · doi:10.1126/science.270.5234.286 · Cited by 2,390
The mechanism of action of cyclosporin A and FK506
Schreiber, S. L., & Crabtree, G. R. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90111-j · Cited by 2,127
Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB
Beg, A. A., Sha, W. C., Bronson, R. T., Ghosh, S., & Baltimore, D. (1995) · Nature · doi:10.1038/376167a0 · Cited by 1,825
Inhibition of NF-κB by Sodium Salicylate and Aspirin
Kopp, E., & Ghosh, S. (1994) · Science · doi:10.1126/science.8052854 · Cited by 1,753
Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids
Scheinman, R. I., Cogswell, P. C., Lofquist, A. K., & Baldwin, A. S. (1995) · Science · doi:10.1126/science.270.5234.283 · Cited by 1,699
Mitchell, J. A., Akarasereenont, P., Thiemermann, C., Flower, R. J., & Vane, J. R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11693 · Cited by 1,659
Anti-inflammatory Actions of Glucocorticoids: Molecular Mechanisms
Barnes, P. J. (1998) · Clinical Science · doi:10.1042/cs0940557 · Cited by 1,591
NF-κB: A lesson in family values
Thanos, D., & Maniatis, T. (1995) · Cell · doi:10.1016/0092-8674(95)90506-5 · Cited by 1,247
Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses
Sha, W. C., Liou, H.-C., Tuomanen, E. I., & Baltimore, D. (1995) · Cell · doi:10.1016/0092-8674(95)90415-8 · Cited by 1,157
Signal transduction through NF-κB
May, M. J., & Ghosh, S. (1998) · Immunology Today · doi:10.1016/s0167-5699(97)01197-3 · Cited by 1,091
Ray, A., & Prefontaine, K. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.752 · Cited by 1,064
The Role of Nuclear Factor- κ B in Cytokine Gene Regulation
Blackwell, T. S., & Christman, J. W. (1997) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.17.1.f132 · Cited by 955
Neurath, M. F., Pettersson, S., Meyer Zum Büschenfelde, K.-H., & Strober, W. (1996) · Nature Medicine · doi:10.1038/nm0996-998 · Cited by 840
Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion.
Brand, K., Page, S., Rogler, G., Bartsch, A., Brandl, R., Knuechel, R., Page, M., Kaltschmidt, C., Baeuerle, P. A., & Neumeier, D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118598 · Cited by 798
Köntgen, F., Grumont, R. J., Strasser, A., Metcalf, D., Li, R., Tarlinton, D., & Gerondakis, S. (1995) · Genes & Development · doi:10.1101/gad.9.16.1965 · Cited by 727
Interleukin (IL)-10 Inhibits Nuclear Factor кB (NFкB) Activation in Human Monocytes
Wang, P., Wu, P., Siegel, M. I., Egan, R. W., & Billah, M. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.16.9558 · Cited by 711
Crofford, L. J., Wilder, R. L., Ristimäki, A. P., Sano, H., Remmers, E. F., Epps, H. R., & Hla, T. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117060 · Cited by 655
Kaltschmidt, B., Uherek, M., Volk, B., Baeuerle, P. A., & Kaltschmidt, C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2642 · Cited by 616
NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules.
Baeuerle, P. A., & Baichwal, V. R. (1997) · PubMed · Cited by 615
Activation of HIV gene expression during monocyte differentiation by induction of NF-kB
Griffin, G. E., Leung, K., Folks, T. M., Kunkel, S., & Nabel, G. J. (1989) · Nature · doi:10.1038/339070a0 · Cited by 582
Transcriptional regulation of the IL-2 gene
Jain, J. (1995) · Current Opinion in Immunology · doi:10.1016/0952-7915(95)80107-3 · Cited by 565
Baeuerle, P. A., & Baichwal, V. R. (1997) · Advances in Immunology · doi:10.1016/s0065-2776(08)60742-7 · Cited by 511
Caldenhoven, E., Liden, J., Wissink, S., Van de Stolpe, A., Raaijmakers, J., Koenderman, L., Okret, S., Gustafsson, J. A., & Van der Saag, P. T. (1995) · Molecular Endocrinology · doi:10.1210/mend.9.4.7659084 · Cited by 489
Role of NFkappaB in the mortality of sepsis.
Böhrer, H., Qiu, F., Zimmermann, T., Zhang, Y., Jllmer, T., Männel, D., Böttiger, B. W., Stern, D. M., Waldherr, R., Saeger, H. D., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119648 · Cited by 454
NF-κB and Rel Proteins in Innate Immunity
(1995) · Advances in Immunology · doi:10.1016/s0065-2776(08)60618-5 · Cited by 428
Mukaida, N., Morita, M., Ishikawa, Y., Rice, N., Okamoto, S., Kasahara, T., & Matsushima, K. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36831-x · Cited by 424
Autoregulation of I kappa B alpha activity.
Chiao, P. J., Miyamoto, S., & Verma, I. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.1.28 · Cited by 423
Read, M. A., Neish, A. S., Luscinskas, F. W., Palombella, V. J., Maniatis, T., & Collins, T. (1995) · Immunity · doi:10.1016/1074-7613(95)90030-6 · Cited by 347
Calcineurin acts in synergy with PMA to inactivate I kappa B/MAD3, an inhibitor of NF-kappa B.
Frantz, B., Nordby, E. C., Bren, G., Steffan, N., Paya, C. V., Kincaid, R. L., Tocci, M. J., O'Keefe, S. J., & O'Neill, E. A. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06329.x · Cited by 334
Molecular mechanisms of anti‐inflammatory action of glucocorticoids
Cato, A. C. B., & Wade, E. (1996) · BioEssays · doi:10.1002/bies.950180507 · Cited by 309
Los, M., Schenk, H., Hexel, K., Baeuerle, P. A., Dröge, W., & Schulze-Osthoff, K. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00043.x · Cited by 303
Pierce, J. W., Read, M. A., Ding, H., Luscinskas, F. W., & Collins, T. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.10.3961 · Cited by 302
Nuclear factor–k B in rheumatoid synovium. Localization of P50 and P65
Handel, M. L., Mcmorrow, L. B., & Gravallese, E. M. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780381209 · Cited by 289
Schwartz, M. D., Moore, E. E., Moore, F. A., Shenkar, R., Moine, P., Haenel, J. B., & Abraham, E. (1996) · Critical Care Medicine · doi:10.1097/00003246-199608000-00004 · Cited by 287
(1995) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60257-2 · Cited by 277
Sequential Induction of NF-κB/Rel Family Proteins during B-Cell Terminal Differentiation
Liou, H.-C., Sha, W. C., Scott, M. L., & Baltimore, D. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.8.5349-5359.1994 · Cited by 266
Weber, C., Erl, W., Pietsch, A., & Weber, P. C. (1995) · Circulation · doi:10.1161/01.cir.91.7.1914 · Cited by 257
NF-IL6 and NF-kappa B in cytokine gene regulation.
Akira, S., & Kishimoto, T. (1997) · PubMed · Cited by 256
The NF-κB/Rel and IκB gene families: mediators of immune response and inflammation
Wulczyn, F. G., Krappmann, D., & Scheidereit, C. (1996) · Journal of Molecular Medicine · doi:10.1007/s001090050078 · Cited by 256
Caldenhoven, E. (1995) · Molecular Endocrinology · doi:10.1210/me.9.4.401 · Cited by 253
Crofford, L. J., Tan, B., McCarthy, C. J., & Hla, T. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400207 · Cited by 248
Kleinert, H., Euchenhofer, C., Ihrig-Biedert, I., & Förstermann, U. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08682-1 · Cited by 233
NF-IL6 and NF-κB in Cytokine Gene Regulation
(1997) · Advances in Immunology · doi:10.1016/s0065-2776(08)60740-3 · Cited by 199
Brostjan, C., Anrather, J., Csizmadia, V., Stroka, D., Soares, M., Bach, F. H., & Winkler, H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19612 · Cited by 198
Roshak, A. K., Jackson, J. R., McGough, K., Chabot-Fletcher, M., Mochan, E., & Marshall, L. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31496 · Cited by 171
Cyclosporine A is an uncompetitive inhibitor of proteasome activity and prevents NF‐κB activation
Meyer, S., Kohler, N. G., & Joly, A. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00930-7 · Cited by 161
Mechanisms of Action of Glucocorticoids in Asthma
Barnes, P. J. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm/154.2_pt_2.s21 · Cited by 149
Glucocorticoids inhibit E-selectin expression by targeting NF-kappaB and not ATF/c-Jun
Brostjan, C., Anrather, J., Csizmadia, V, Natarajan, G., & Winkler, H. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.8.3836 · Cited by 140
Okamoto, S., Mukaida, N., Yasumoto, K., Rice, N. R., Ishikawa, Y., Horiguchi, H., Murakami, S., & Matsushima, K. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37234-4 · Cited by 139
Sequential induction of NF-kappa B/Rel family proteins during B-cell terminal differentiation.
Liou, H. C., Sha, W. C., Scott, M. L., & Baltimore, D. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.8.5349 · Cited by 137
Sakurada, S., Kato, T., & Okamoto, T. (1996) · International Immunology · doi:10.1093/intimm/8.10.1483 · Cited by 121
Modification of vascular responses in xenotransplantation: Inflammation and apoptosis
Bach, F. H., Ferran, C. J., Soares, M. P., Wrighton, C. J., Anrather, J., Winkler, H. J. S., Robson, S. C., & Hancock, W. W. (1997) · Nature Medicine · doi:10.1038/nm0997-944 · Cited by 111
Cockerill, G., Bert, A. G., Ryan, G., Gamble, J. R., Vadas, M., & Cockerill, P. (1995) · Blood · doi:10.1182/blood.v86.7.2689.2689 · Cited by 100
FK506 inhibits antigen receptor-mediated induction of c-rel in B and T lymphoid cells.
Venkataraman, L., Burakoff, S. J., & Sen, R. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.3.1091 · Cited by 90
Stacey, M. A., Sun, G. Y., Vassalli, G., Marini, M. A., Bellini, A., & Mattoli, S. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6997 · Cited by 86
Transcriptional Regulation of Endothelial Cell Adhesion Molecules: A Dominant Role for NF-κB
Chen, C. C., & Manning, A. (1995) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7343-7_12 · Cited by 84
Molecular chaperones and the biosynthesis of antigen receptors
Melnick, J., & Argon, Y. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80167-7 · Cited by 83
The Effect of Dexamethasone on the Expression of Activated NF-κB in Adjuvant Arthritis
Tsao, P. W., Suzuki, T., Totsuka, R., Murata, T., Takagi, T., Ohmachi, Y., Fujimura, H., & Takata, I. (1997) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1997.4333 · Cited by 82
Molecular Mechanisms of Immunosuppression and Anti-inflammatory Activities by Glucocorticoids
Didonato, J. A., Saatcioglu, F., & Karin, M. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm/154.2_pt_2.s11 · Cited by 79
The NF-kappaB transcription factor in oncogenesis.
Sharma, H. W., & Narayanan, R. (1996) · PubMed · Cited by 78
Multi-Step Activation of NF-κB/Rel Transcription Factors
Schmitz, M. L., & Baeuerle, P. A. (1995) · Immunobiology · doi:10.1016/s0171-2985(11)80534-6 · Cited by 77
Marienfeld, R. B., Neumann, M., Chuvpilo, S. A., Escher, C., Kneitz, B., Avots, A., Schimpl, A., & Serfling, E. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270703 · Cited by 77
Characterization of IκB Kinases
Janosch, P., Schellerer, M., Seitz, T., Reim, P., Eulitz, M., Brielmeier, M., Kölch, W., Sedivy, J. M., & Mischak, H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.23.13868 · Cited by 76
Kazmi, S. M. I., Plante, R. K., Visconti, V., Taylor, G. R., Zhou, L., & Lau, C. Y. (1995) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240570214 · Cited by 76
Tepper, M. A., Nadler, S. G., Esselstyn, J. M., & STERBENZ, K. G. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.5.2427 · Cited by 74
Regulation of the DNA binding activity of NF-κB
Matthews, J. R., & Hay, R. T. (1995) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/1357-2725(95)00071-v · Cited by 71
Segars, J. H., Nagata, T., Bours, V., Medin, J. A., Franzoso, G., Blanco, J. C. G., Drew, P. D., Becker, K. G., An, J., Tang, T. L., et al. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6157 · Cited by 71
Induction of IL-8 expression in T cells uses the CD28 costimulatory pathway.
Wechsler, A. S., Gordon, M. C., Dendorfer, U., & LeClair, K. P. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.6.2515 · Cited by 67
Kunz, D., Walker, G., Eberhardt, W., Nitsch, D., & Pfeilschifter, J. M. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2642 · Cited by 51
Cyclosporin A sensitivity of the NF-χB site of the IL2Rα promoter in untransformed murine T cells
McCaffrey, P. G., Kim, P. K., Valge-archer, V. E., Sen, R., & Rao, A. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.11.2134 · Cited by 42
Adcock, I. M., BROWN, C. R., & Barnes, P. J. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1209 · Cited by 33
Weissmann, G. (1991) · Hospital Practice · doi:10.1080/21548331.1991.11705279 · Cited by 33
Accommodation of xenografts: Expression of “protective genes” in endothelial and smooth muscle cells
Bach, F. H., Ferran, C. J., Candinas, D., Miyatake, T., Koyamada, N., Mark, W., Hechenleitner, P., & Hancock, W. W. (1997) · Transplantation Proceedings · doi:10.1016/s0041-1345(96)00009-7 · Cited by 30
Aspirin inhibits expression of the interleukin‐1β‐inducible group II phospholipase A2
Vervoordeldonk, M. J., Pineda‐Torra, I., Aarsman, A. J., & van den BOSCH, H. (1996) · FEBS Letters · doi:10.1016/s0014-5793(96)01148-9 · Cited by 30
Cytokine-modulating activity of tepoxalin, a new potential antirheumatic
Ritchie, D. M., Argentieri, D. C., Aparicio, B. L., Plante, R. K., Lau, C. Y., & Barbone, A. G. (1995) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(95)00072-a · Cited by 21
Kappa B binding proteins are constitutively expressed in an IL-2 autocrine human T cell line
Hémar, A., Cereghini, S., Cornet, V., Blank, V., Israël, A., Greene, W. C., & Dautry‐Varsat, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.7.2409 · Cited by 21
Cited by
Milk thistle in liver diseases: past, present, future
Abenavoli, L., Capasso, R., Milic, N., & Capasso, F. (2010) · Phytotherapy Research · doi:10.1002/ptr.3207 · Cited by 599
Shakoor, H., Feehan, J., Al Dhaheri, A. S., Ali, H. I., Platat, C., Ismail, L. C., Apostolopoulos, V., & Stojanovska, L. (2021) · Maturitas · doi:10.1016/j.maturitas.2020.08.003 · Cited by 465
“Inhibition of NF-кB can be a therapeutic mode against viral infections [29].”
Antioxidant and prooxidant mechanisms in the regulation of redox(y)-sensitive transcription factors
Haddad, J. J. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(02)00053-0 · Cited by 427
Multiple Molecular Penumbras after Focal Cerebral Ischemia
Sharp, F. R., Lu, A., Tang, Y., & Millhorn, D. E. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200007000-00001 · Cited by 403
TNF ligands and receptors – a matter of life and death
MacEwan, D. J. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704549 · Cited by 391
Metadata
- Authors
- Lee, J., & Burckart, G. J.
- Venue
- The Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 1998-11
- Volume
- 38
- Issue
- 11
- Pages
- 981-993
- ISSN
- 0021-9754 (ISSN-L)
- 0091-2700
- 1552-4604
- OpenAlex
- W1963709111
- Cited by
- 365
- References
- 81
- FWCI
- 6.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.